National Vaccine Adverse Event Reporting Survey and Etiology

Clinical trial NCT05095844 · UNKNOWN

Trial details

NCT number: NCT05095844
Sponsor: Neuroganics LLC
Status: UNKNOWN
Study type: OBSERVATIONAL

COVID-19 Vaccine Adverse Reaction Vaccine Reaction Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use Corona Virus Infection Blood Clot Thrombocytopenia Neuritis Vasculitis Influenza Guillain-Barré GWAS

Start date: 2022-03-15
Primary completion: 2024-04-01
Enrollment: 100000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.